Seven Eight Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-57,188
| Closed | -$537K | – | 298 |
|
|
2024
Q3 | $537K | Sell |
57,188
-20,052
| -26% | -$188K | 0.05% | 541 |
|
|
2024
Q2 | $619K | Sell |
77,240
-97,162
| -56% | -$779K | 0.06% | 474 |
|
|
2024
Q1 | $2.58M | Buy |
+174,402
| New | +$2.58M | 0.27% | 109 |
|
|
2023
Q4 | – | Sell |
-319,502
| Closed | -$1.45M | – | 723 |
|
|
2023
Q3 | $1.45M | Buy |
319,502
+187,253
| +142% | +$852K | 0.17% | 158 |
|
|
2023
Q2 | $931K | Buy |
132,249
+73,325
| +124% | +$516K | 0.15% | 190 |
|
|
2023
Q1 | $360K | Sell |
58,924
-151,476
| -72% | -$926K | 0.08% | 302 |
|
|
2022
Q4 | $1.34M | Buy |
210,400
+159,194
| +311% | +$1.02M | 0.35% | 86 |
|
|
2022
Q3 | $491K | Sell |
51,206
-54,574
| -52% | -$523K | 0.1% | 286 |
|
|
2022
Q2 | $1.17M | Buy |
105,780
+85,394
| +419% | +$943K | 0.47% | 54 |
|
|
2022
Q1 | $339K | Buy |
+20,386
| New | +$339K | 0.05% | 388 |
|
|
2021
Q4 | – | Sell |
-64,556
| Closed | -$1.59M | – | 571 |
|
|
2021
Q3 | $1.59M | Buy |
64,556
+600
| +0.9% | +$14.8K | 0.15% | 223 |
|
|
2021
Q2 | $1.66M | Buy |
+63,956
| New | +$1.66M | 0.23% | 136 |
|
|
2020
Q3 | – | Sell |
-9,397
| Closed | -$258K | – | 589 |
|
|
2020
Q2 | $258K | Buy |
+9,397
| New | +$258K | 0.19% | 218 |
|
|
2018
Q4 | – | Sell |
-27,600
| Closed | -$311K | – | 616 |
|
|
2018
Q3 | $311K | Buy |
+27,600
| New | +$311K | 0.02% | 510 |
|